A 77-Year-Old Woman with DLBCL

home / case-based-peer-perspectives / a-77-year-old-woman-with-dlbcl

John M. Burke, MD, of Rocky Mountain Cancer Centers, explains the rationale behind treating an elderly woman with relapsed diffuse large B-cell lymphoma with tafasitamab and lenalidomide after R-CHOP chemotherapy.

EP. 1: Case Overview: 77-Year-Old Woman With DLBCL

John M. Burke, MD

September 25th 2020

Watch

EP. 2: Approaching DLBCL: Risk Assessment and Prognosis

John M. Burke, MD

September 25th 2020

Watch

EP. 3: DLBCL: Cytogenetic Testing and Treatment Initiation

John M. Burke, MD

September 25th 2020

Watch

EP. 4: Frontline Treatment Approaches in DLBCL

John M. Burke, MD

September 25th 2020

Watch

EP. 5: Current Treatment Approaches for R/R DLBCL

John M. Burke, MD

September 25th 2020

Watch

EP. 6: Implications for Treating R/R DLBCL With the L-MIND Regimen

John M. Burke, MD

September 25th 2020

Watch

EP. 7: R/R DLBCL: Observations From the Re-MIND Study

John M. Burke, MD

September 25th 2020

Watch

EP. 8: R/R DLBCL: Treating With Tafasitamab Plus Lenalidomide

John M. Burke, MD

September 25th 2020

Watch

EP. 9: Progress Made in Treating R/R DLBCL

John M. Burke, MD

September 25th 2020

Watch